Perimenopause is often described as a reproductive transition, which is true but incomplete. Oestrogen and progesterone fluctuations also touch sleep, appetite, fat distribution, muscle, liver metabolism, and insulin sensitivity. That does not mean every woman becomes insulin resistant at midlife. It means the metabolic background changes, and the usual advice to “eat less and move more” becomes too blunt.
The hormone shift is not only reproductive
Insulin resistance means the body needs more insulin than before to move glucose out of the bloodstream and into tissues such as muscle and liver. It can sit quietly for years before fasting glucose or HbA1c crosses into prediabetes. Perimenopause matters because it arrives during the same years when sleep worsens, muscle mass can decline, stress load often rises, and central body fat becomes easier to gain.
Oestrogen is part of this picture. It influences where fat is stored, how skeletal muscle handles glucose, how the liver manages lipids, and how blood vessels respond to metabolic strain. As ovarian function becomes more erratic, the metabolic signal is not simply “low oestrogen”. It is fluctuation, followed by a lower postmenopausal baseline, layered onto ageing and lifestyle.
The distinction matters. If we blame every glucose change on menopause, we miss treatable drivers. If we ignore menopause entirely, we leave women thinking they have failed when the physiology has shifted under them.
What the longitudinal evidence shows
The strongest midlife evidence comes from following women over time, rather than comparing younger and older women once. In the Study of Women’s Health Across the Nation, about 13% of perimenopausal women developed metabolic syndrome over five years. After adjustment, education was the independent predictor in that analysis — a reminder that social and behavioural factors shape risk alongside biology.
A related SWAN analysis, published in the menopause and metabolic syndrome literature, linked menopausal progression and relative androgen excess to new-onset metabolic syndrome through the final menstrual period. Metabolic syndrome also becomes more common from premenopause to postmenopause in several analyses. That does not prove ovarian ageing is the only cause. It does point to a real midlife risk window.
The practical signal is not that perimenopause causes diabetes. It is that the transition can reveal vulnerability: a family history of type 2 diabetes, prior gestational diabetes, abdominal weight gain, poor sleep, lower activity, or a creeping blood-pressure change.
Sleep disruption is a metabolic problem
Hot flushes and night sweats are usually discussed as comfort symptoms. Metabolically, they matter because they fragment sleep. Repeated short nights can worsen appetite regulation, sympathetic nervous-system tone, and glucose handling. A woman who is sleeping five broken hours and waking drenched is not starting from the same metabolic baseline as she was at 38.
This is one reason symptom treatment should not be treated as cosmetic. If vasomotor symptoms are driving insomnia, then treating the symptoms may indirectly help the behaviours that protect insulin sensitivity: resistance training, meal planning, lower alcohol intake, and enough recovery to be active.
That does not mean HRT is a diabetes treatment. It means sleep is not a side issue. For some women, the path to better metabolic health begins with taking night sweats seriously.
Body composition changes the glucose equation
Muscle is a major glucose-disposal organ. Lose muscle, gain visceral fat, and insulin has a harder job. This is why midlife weight change feels different for many women. The scale may move only modestly whilst waist circumference, strength, and glucose numbers shift in the wrong direction.
A 2022 review of metabolic disorders in menopause describes the postmenopausal rise in cardiometabolic disease risk, including central adiposity, type 2 diabetes, cardiovascular disease, and fatty liver disease. Reviews like this can make the story sound deterministic. It is not. The more useful reading is that body composition becomes a higher-yield target than weight alone.
Resistance training is therefore not just a fitness recommendation. It is glucose infrastructure. So are adequate protein, fibre-rich meals, and regular walking after meals. None of these cancels ovarian ageing. They improve the tissues insulin is trying to act on.
Testing should be boring and useful
The common mistake is to chase an elaborate hormone panel when the more actionable metabolic checks are ordinary: HbA1c, fasting glucose, blood pressure, waist circumference, lipid panel, liver enzymes where appropriate, and a history of gestational diabetes or polycystic ovary syndrome.
For women with symptoms of reactive lows, known diabetes, or conflicting results, a clinician may consider additional testing. But for most midlife women, the first question is not whether oestradiol was high or low on a Tuesday. It is whether the risk markers that predict future disease are changing.
Diabetes UK notes that hormonal changes in perimenopause can disrupt blood sugar levels and make diabetes harder to manage, whilst also emphasising physical activity, food quality, and clinical support. That is a balanced position: menopause can complicate glucose control, but it does not remove agency or the need for standard risk management.
Where HRT fits, and where it does not
Menopausal hormone therapy has an interesting metabolic signal. A review on menopausal hormone therapy and type 2 diabetes prevention reports that large randomised trials suggest MHT can delay the onset of type 2 diabetes in postmenopausal women. More recent analyses have also explored glucose regulation in women with diabetes.
But indication matters. HRT is prescribed primarily for menopausal symptoms and, in selected cases, bone protection. It is not first-line diabetes prevention. A woman with severe night sweats, early postmenopause, and low baseline risk may reasonably discuss HRT, and improved sleep may make training and nutrition easier. A woman with high clotting risk, breast cancer history, or late initiation has a different risk equation.
The best version of the conversation is neither “HRT will fix your metabolism” nor “HRT is irrelevant”. It is: what symptoms are we treating, what risks are present, what formulation is being considered, and what metabolic markers will we follow?
What this means in practice
- Track waist circumference, blood pressure, HbA1c, fasting glucose, and lipids through the transition rather than relying on weight alone.
- Treat persistent night sweats and insomnia as metabolic stressors, not just quality-of-life complaints.
- Prioritise resistance training two to four times per week, because muscle is central to glucose disposal.
- Build meals around protein, fibre, and minimally processed carbohydrates; the goal is steadier glucose, not dietary punishment.
- Use walking after meals as a low-friction glucose tool, especially after higher-carbohydrate meals.
- Discuss HRT for symptoms and individual risk, not as a stand-alone diabetes-prevention strategy.
What we don’t know
We do not yet have a perfect map of which perimenopausal women will develop insulin resistance and which will not. Ethnicity, prior pregnancy history, genetics, sleep, socioeconomic pressure, medication use, activity, and baseline body composition all matter. Many studies also use different definitions of menopause stage, insulin resistance, and metabolic syndrome, which makes clean comparisons difficult.
We also do not know whether treating vasomotor symptoms early changes long-term diabetes outcomes, independent of weight, sleep, and activity. That is plausible, but not proven. The most honest position is narrower: perimenopause can shift the metabolic terrain, and women with rising risk markers deserve earlier, more specific attention.
Insulin resistance at midlife is not a personal failure, and it is not destiny. It is a signal to measure the right things, protect muscle, take sleep seriously, and make menopause care part of cardiometabolic prevention rather than a separate conversation.
Photo: Pavel Danilyuk on Pexels.